ArticleJournal of controlled release : official journal of the Controlled Release Society2013

A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome.

Mihir Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.